04:31 PM EST, 03/07/2024 (MT Newswires) -- Mark Sabag, Executive Vice President, International Markets, on March 05, 2024, sold 100,000 shares in Teva Pharmaceutical Industries ( TEVA ) for $1,352,090. Following the Form 4 filing with the SEC, Sabag has control over a total of 382,590 shares of the company, with 382,590 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/818686/000095017024027959/xslF345X03/ownership.xml

Price: 13.66, Change: -0.05, Percent Change: -0.36